Levitas Bio partners with Planet Innovation to develop and manufacture the world’s first label-free cell separation platform
14 September 2020 Silicon Valley start-up Levitas Bio has launched the world’s first label-free cell separation platform, the LeviCell™. The benchtop device uses revolutionary magnetic levitation technology developed at Stanford University to sort cell populations, without modifying the cells with…
Supporting Victorian Businesses On Our Road To COVID Normal
13 September 2020 Read the original media release here. A massive new support package will see $3 billion in cash grants, tax relief and cashflow support delivered to Victorian businesses as we work together to drive coronavirus cases…
Impact to R&D Tax Incentive claims by COVID-19 or Bushfires 2019-20
11 September 2020 This information is provided by AusIndustry. Read more via AusIndustry here. Aware that COVID-19 and the recent bushfires may have affected your economic circumstances, applications for the Research and Development Tax Incentive have been extended…
Opthea Appoints US-Based Non-Executive Director
10 September 2020 The directors of Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, are pleased to announce the appointment of Mr Daniel Spiegelman as an…
Locked And Loaded: Using Genomic Sequencing To Target Covid-19’s Weak Spots
10 September 2020 Originally published via the University of Melbourne by Stephanie Portelli, Elston D’Souza and Associate Professor David Ascher COVID-3D, a new open-access tool harnesses SARS-CoV-2 genomic and structural information to help ensure therapeutic efforts remain effective.…
Noxopharm Appoints New Chair
10 September 2020 Release date 9 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announces the appointment of Mr Fred Bart as Non-Executive Chair, allowing ExecutiveChair and CEO, Dr Graham Kelly, to focus on the CEO…
Local Response Units And Boosted Reporting For Safe Next Steps
10 September 2020 Release date 8 September 2020 New Suburban Response Units will be set up to give rapid local insights and leverage community connections to help keep localised outbreaks contained, as Victoria takes the first steps to…
Global CRO To Execute Noxopharm DARRT-2 Prostate Cancer Study
10 September 2020 Release date 8 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce that after a rigorous global search, the clinical research organisation (CRO), Parexel® Biotech, has been appointed to manage…
Allens: Capturing the hydrogen opportunity for Australia and Japan
10 September 2020 Now is the time to look for future global opportunities Australia’s hydrogen industry is expected to contribute at least $11 billion to the national economy and generate around 7,600 jobs by 2050. In the current state of play,…
New drug shown to improve bone growth in children with achondroplasia in global phase III trial
10 September 2020 Release date 4 September 2020 A phase three global clinical trial led by the Murdoch Children’s Research Institute (MCRI) has shown a new drug boosts bone growth in children born with achondroplasia, the most common type of…
New AusBiotech industry Advisory Group Chairs appointed
10 September 2020 Release date 3 September 2020 AusBiotech welcomes its new industry Advisory Group Chairs: Dr Megan Robertson, St Vincent’s Hospital Melbourne, Chair of the AusBiotech Clinical Trials Adivsory Group; and Dr Amanda Gillon, Bioscience Managers, Chair…
Cynata Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study
7 September 2020 Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive efficacy data from a study of its induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal…
